首页 | 本学科首页   官方微博 | 高级检索  
     

卡介苗加白细胞介素-2膀胱灌注治疗56例膀胱移行细胞癌
引用本文:杨兵,叶锦. 卡介苗加白细胞介素-2膀胱灌注治疗56例膀胱移行细胞癌[J]. 现代医药卫生, 2004, 20(7): 506-507
作者姓名:杨兵  叶锦
作者单位:1. 南桐矿务局总医院外科,重庆万盛,400802
2. 第三军医大学大坪医院野战外科研究所泌尿外科,重庆,400042
摘    要:目的 :观察卡介苗加白介素 -2(IL-2)膀胱灌注治疗膀胱移行细胞癌的疗效。方法 :回顾性分析膀胱移行细胞癌患者接受卡介苗 (BCG)加IL—2膀胱灌注预防术后复发的效果。结果 :本组56例 ,随访4~72月 ,平均38月 ,复发9例 ,复发率为16 1% ,疗效较满意。结论 :卡介苗加IL-2可作为膀胱移行细胞癌术后的常规治疗

关 键 词:卡介苗  白细胞介素2  膀胱移行细胞癌
文章编号:1009-5519(2004)07-0506-02
修稿时间:2003-12-12

Treatment of 56 cases of vesical transitional cell carcinoma with bacillus Calmette-Guerin and interleukin-2 by intravesical perfusion
YANG Bing ,YE Jin. Treatment of 56 cases of vesical transitional cell carcinoma with bacillus Calmette-Guerin and interleukin-2 by intravesical perfusion[J]. JOURNAL OF MODERN MEDICINE & HEALTH, 2004, 20(7): 506-507
Authors:YANG Bing   YE Jin
Affiliation:YANG Bing 1,YE Jin 2
Abstract:Objective:To observe the curative effect of bacillus Calmette-Guerin(BCG)plus interleukin-2(IL-2)for treating vesical transitional cell carcinoma(TCC)by intravesical perfusion.Methods:The effect of BCG plus IL-2by intravesical perfusion for preventing post-operative recurrence of vesical TCC was analysed retrospectively.Reuslts:56cases in this group were followed up for4to72months with an av-erage of38months.9cases relapsed and the recurrence rate was16.1%.The curative effect of intravesical perfusion was satisfactory.Conclusion:BCG combined with IL-2may be used as a routine treatment for vesical TCC.
Keywords:Bacillus Calmette-Guerin  Interleukin-2  Vesical transitional cell carcinoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号